February 18, 2022
According to the research report titled ‘Lactoferrin Market Size By Product (Apolactoferrin, Hololactoferrin), By Form (Capsules, Powder, Others), By Source (Rice Flour, Human Milk, Animal Milk {Bovine Milk, Porcine Milk, Caprine Milk, Ovine Milk}), By Function (Iron Absorption, Anti-Inflammatory, Intestinal Flora Protection, Antibacterial, Immune Cell Stimulation, Antioxidants), By Application (Food & Beverage Products, Infant Formula, Sports & Functional Foods, Pharmaceuticals, Cosmetic & Personal Care Products, Animal Feed), By Distribution Channel (Supermarket/Hypermarket, Online, Drugstore, Nutrition & Health Food Store) Industry Analysis Report, Country Outlook Application Development, Price Trends, Competitive Market Share & Forecast, 2021 – 2027’, available with MarketStudyReport, global lactoferrin market is anticipated to witness a healthy CAGR over the analysis period 2021-2027.
Factors such as increasing presence of physical training institutes and gyms, health benefits of the product, and surging demand across various application avenues such as pharmaceuticals and F&B are propelling global lactoferrin market growth.
Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3692113/
For the unversed, lactoferrin is a protein that is commonly present in milk from humans and cows. It is also found in various other bodily fluids in humans like bile, tears, mucus, and saliva. The protein is found in abundance in colostrum, which is the first breast milk produced after a baby is born.
Despite the positive outlook, high costs, issues with innovation & sustainability, and increasing efforts towards promoting breast feeding are likely to impede market development in the upcoming years.
Considering form based segmentation of worldwide lactoferrin industry, others segment is expected to grow at 5.9% CAGR over the forecast period.
Based on source type, porcine milk segment is expected to be worth USD 4 million by the end of 2027, while the caprine milk sub segment is expected to be valued at USD 8 million by the end of the stipulated timeframe.
Speaking of function type, the intestinal flora protection segment amassed USD 20 million in 2020 and is poised to register 6.9% CAGR over 2021-2027.
By application scope, the animal feed segment was evaluated at USD 8.4 million in 2020 and is estimated to deliver a CAGR of 7% over the analysis timeline.
From a regional frame of reference, Latin America industry garnered a valuation of USD 12.5 million and is touted to register a CAGR of 5.7% over the analysis timeframe.
Major contenders in global lactoferrin market are ND Pharma & Biotech Co. Ltd., Royal FrieslandCampina N.V., Warrnambool Cheese & Butter Factory Company Holdings Ltd. (WCB), Ferrin-Tech LLC, Bega Cheese Ltd., Hoogwegt Group B.V., InVitria, Fonterra Co-operative Group Ltd., MILEI GmbH, Farbest Brands, Glanbia plc, APS BioGroup Inc., Westland Dairy Co. Ltd., MP Biomedicals, Metagenics Inc., Synlait Ltd., and Pharming Group N.V.